The results revealed that RUNX1 expression is substantially higher in the majority of digestive system tumors (Figure 1A; Supplementary Figure 1A), suggesting a potential pro-oncogenic function of RUNX1 in the human digestive system. Here, RUNX1 is linked to digestive system neoplasm.